Epoch Investment Partners, Inc. Abb Vie Inc. Transaction History

Epoch Investment Partners, Inc.

$21.7 Billion
Q3 2024

A detailed history of Epoch Investment Partners, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Epoch Investment Partners, Inc. holds 917,770 shares of ABBV stock, worth $161 Million. This represents 0.84% of its overall portfolio holdings.

Number of Shares

917,770

Previous 929,447 1.26%

Holding current value

$161 Million

Previous $159 Million 13.69%

% of portfolio

0.84%

Previous 0.75%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$163.84 - $199.33 $1.91 Million - $2.33 Million	-11,677 Reduced 1.26%	917,770 $181 Million
Q2 2024 Aug 13, 2024	SELL	$154.79 - $180.76 $7.01 Million - $8.18 Million	-45,255 Reduced 4.64%	929,447 $159 Million
Q1 2024 May 14, 2024	SELL	$159.82 - $182.1 $23.2 Million - $26.5 Million	-145,431 Reduced 12.98%	974,702 $177 Million
Q4 2023 Feb 13, 2024	SELL	$137.6 - $154.97 $7.96 Million - $8.97 Million	-57,875 Reduced 4.91%	1,120,133 $174 Million
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $13.5 Million - $15.6 Million	-101,108 Reduced 7.9%	1,178,008 $176 Million
Q2 2023 Aug 11, 2023	SELL	$132.51 - $164.9 $8.1 Million - $10.1 Million	-61,107 Reduced 4.56%	1,279,116 $172 Million
Q1 2023 May 12, 2023	SELL	$144.61 - $166.54 $3.65 Million - $4.21 Million	-25,273 Reduced 1.85%	1,340,223 $214 Million
Q4 2022 Feb 13, 2023	SELL	$138.31 - $165.87 $15.7 Million - $18.9 Million	-113,652 Reduced 7.68%	1,365,496 $221 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $7.42 Million - $8.51 Million	55,264 Added 3.88%	1,479,148 $199 Million
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $20.9 Million - $26.5 Million	-151,632 Reduced 9.62%	1,423,884 $218 Million
Q1 2022 May 13, 2022	SELL	$131.98 - $163.75 $13.6 Million - $16.9 Million	-102,975 Reduced 6.13%	1,575,516 $255 Million
Q4 2021 Feb 11, 2022	SELL	$107.43 - $135.93 $8.78 Million - $11.1 Million	-81,683 Reduced 4.64%	1,678,491 $227 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $187 Million - $213 Million	1,760,174 New	1,760,174 $190 Million
Q2 2021 Aug 13, 2021	SELL	$105.21 - $117.21 $29.9 Million - $33.3 Million	-284,206 Reduced 13.77%	1,780,269 $201 Million
Q1 2021 May 17, 2021	SELL	$102.3 - $112.62 $8.65 Million - $9.52 Million	-84,556 Reduced 3.93%	2,064,475 $223 Million
Q4 2020 Feb 12, 2021	SELL	$80.49 - $108.67 $168 Million - $227 Million	-2,090,399 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$85.91 - $100.83 $776,798 - $911,704	-9,042 Reduced 0.43%	2,090,399 $183 Million
Q2 2020 Aug 13, 2020	SELL	$73.37 - $98.18 $4.4 Million - $5.89 Million	-59,994 Reduced 2.78%	2,099,441 $206 Million
Q1 2020 May 14, 2020	BUY	$64.5 - $97.79 $24.9 Million - $37.7 Million	385,517 Added 21.73%	2,159,435 $165 Million
Q4 2019 Feb 13, 2020	BUY	$72.13 - $90.25 $15.1 Million - $18.9 Million	209,886 Added 13.42%	1,773,918 $157 Million
Q3 2019 Nov 13, 2019	SELL	$62.98 - $75.72 $1.44 Million - $1.73 Million	-22,874 Reduced 1.44%	1,564,032 $118 Million
Q2 2019 Aug 13, 2019	BUY	$65.7 - $83.98 $1.42 Million - $1.81 Million	21,587 Added 1.38%	1,586,906 $115 Million
Q1 2019 May 14, 2019	BUY	$77.14 - $90.79 $8.85 Million - $10.4 Million	114,693 Added 7.91%	1,565,319 $126 Million
Q4 2018 Feb 13, 2019	SELL	$77.85 - $96.01 $13.8 Million - $17 Million	-177,423 Reduced 10.9%	1,450,626 $134 Million
Q3 2018 Nov 13, 2018	BUY	$88.91 - $98.84 $4.66 Million - $5.19 Million	52,463 Added 3.33%	1,628,049 $154 Million
Q2 2018 Aug 13, 2018	SELL	$89.78 - $106.23 $81.7 Million - $96.7 Million	-910,398 Reduced 36.62%	1,575,586 $146 Million
Q1 2018 May 14, 2018	SELL	$92.01 - $123.21 $422 Million - $565 Million	-4,588,115 Reduced 64.86%	2,485,984 $235 Million
Q4 2017 Feb 13, 2018	SELL	$89.56 - $98.21 $70.8 Million - $77.7 Million	-790,991 Reduced 10.06%	7,074,099 $684 Million
Q3 2017 Nov 13, 2017	BUY	$69.85 - $89.22 $549 Million - $702 Million	7,865,090	7,865,090 $699 Million

Others Institutions Holding ABBV

# of Institutions

3,852

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Epoch Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Epoch Investment Partners, Inc. with notifications on news.

Account

Epoch Investment Partners, Inc. Abb Vie Inc. Transaction History